Author:
Lu Justin Y.,Tiwari Arun K.,Zai Gwyneth C.,Rastogi Anjali,Shaikh Sajid A.,Müller Daniel J.,Voineskos Aristotle N.,Potkin Steven G.,Lieberman Jeffrey A.,Meltzer Herbert Y.,Remington Gary,Wong Albert H.C.,Kennedy James L.,Zai Clement C.
Funder
Genome Canada Genomic Applications Partnership Program (GAPP)
CAMH Foundation
Canadian Institutes of Health Research
National Institutes of Health
Centre for Addiction and Mental Health Foundation (Joanne Murphy Professorship)
Research Hospital Fund - Canadian Foundation for Innovation (RHF-CFI)
Reference77 articles.
1. Epidemiology, prevention, and assessment of tardive dyskinesia and advances in treatment;Correll;J. Clin. Psychiatry,2017
2. Tardive dyskinesia in the era of typical and atypical antispychotics;Margolese;Can. J. Psychiatry,2005
3. Movement disorders associated with antipsychotic medication in people with schizophrenia: an overview of cochrane reviews and meta-analysis;Martino;Canad. J. Psychiatry Revue canadienne de psychiatrie,2018
4. Tardive syndromes and other drug-induced movement disorders;Jankovic;Clin. Neuropharmacol.,1995
5. An update on tardive dyskinesia: from phenomenology to treatment;Waln;Tremor Other Hyperkinet. Mov. (N. Y.),2013
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献